← All companies

HCWB

HCW Biologics Inc.

HCWB Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.34

+0.19 +6.03%

Key statistics

from XBRL data in SEC filings

Market cap

$22.5M

Revenue (TTM)

$6.55M

Net income (TTM)

-$2.29M

EPS (TTM)

$-8.29

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$1.23M

Total assets

$27.3M

Gross margin

99.9%

52-week range

$1.50 – $44.10

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jul 29, 2026 8-K Other events Jul 1, 2026 8-K Delisting notice or listing-rule failure Jun 30, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jun 26, 2026 8-K Regulation FD disclosure Jun 16, 2026 8-K Shareholder vote results Jun 15, 2026 8-K Delisting notice or listing-rule failure Jun 1, 2026 8-K Terminated a material agreement May 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Other events Apr 30, 2026 8-K Other events Apr 30, 2026 8-K Amended charter or bylaws Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Entered a material agreement Mar 17, 2026 8-K Delisting notice or listing-rule failure Mar 2, 2026 8-K Entered a material agreement; Regulation FD disclosure; Other events Feb 19, 2026 8-K Entered a material agreement Feb 13, 2026 8-K Other events Dec 31, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Nov 20, 2025 8-K Entered a material agreement Nov 19, 2025 8-K Regulation FD disclosure Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Delisting notice or listing-rule failure Oct 16, 2025 8-K Entered a material agreement Sep 5, 2025 8-K Delisting notice or listing-rule failure Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 18, 2025 8-K/A Results of operations (earnings release) Aug 18, 2025 8-K Entered a material agreement Aug 15, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement Jul 18, 2025 8-K Other events Jul 1, 2025 8-K Other events Jun 26, 2025 8-K Director or officer change; Shareholder vote results; Other events Jun 23, 2025 8-K Other events Jun 13, 2025 8-K Other events Jun 5, 2025 8-K Entered a material agreement; Other events Jun 4, 2025